GlassScriptPhysician profile
Lacey Beth Lockhart
NPI 1497149454
$1,564.63
in general payments reported to CMS, 2019-2025
15 companies · $438 in 2025
The $438 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.22 · 2020: $15.11 · 2021: $69.16 · 2022: $436 · 2023: $355 · 2024: $154 · 2025: $438.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $714 · Travel and Lodging: $234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $713.59 |
| Travel and Lodging | $234.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $262.05 | 2022-2023 | |
| Paragon 28, INC. | $250.76 | 2021-2025 | Precision Mis Bunion, Bun-Yo-Matic |
| Stryker Corporation | $241.11 | 2022-2025 | Augment Injectable, Iconix, Omega |
| Organogenesis INC. | $154.71 | 2022-2023 | Puraply |
| Smith+Nephew, INC. | $150.09 | 2020-2022 | |
| Depuy Synthes Sales INC. | $140.34 | 2019-2025 | Na |
| Acera Surgical, INC. | $99.04 | 2024 | Restrata Wound Matrix |
| Globus Medical, INC. | $89.41 | 2025 | Senza |
| Medtronic, INC. | $48.16 | 2023 | Venaseal |
| Nevro Corp. | $32.57 | 2023 | Senza |
| Biocomposites INC | $26.82 | 2025 | Stimulan |
| Abbott Laboratories | $24.48 | 2022 | |
| Grt US Holding, INC. | $15.83 | 2022 | |
| Bioventus LLC | $15.10 | 2022 | |
| Solventum Corporation | $14.16 | 2025 | Activ.A.C. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lacey Beth Lockhart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.